NEW YORK, Oct. 13, 2022 /PRNewswire/ -- The global in-vitro diagnostics market size is expected to increase by USD 33.16 billion, accelerating at a CAGR of 6.89% during the forecast period. According to the report by Technavio, the market will observe the highest incremental growth in North America. The region will account for 35% of the global market share over the forecast period. Factors such as increased insurance coverage, rise in R&D expenditure, and the growth of the geriatric population with chronic diseases are significantly contributing to the growth of the regional market. Explore future growth opportunities across various regions in detail. Buy Report Now
The market is driven by factors such as the increasing geriatric population, chronic, and infectious diseases, high demand for personalized medicine, and increasing investments in drug discovery. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments while maintaining their positions in the slow-growing segments.
The report covers the following areas:
- In-vitro Diagnostics Market size
- In-vitro Diagnostics Market trends
- In-vitro Diagnostics Market industry analysis
In-vitro Diagnostics Market 2022-2026: Segmentation
- Technology
- Immunoassay
- Molecular Diagnostics
- Clinical Chemistry
- Hematology
- Others
The market growth in the immunoassay segment will be significant during the forecast period. Immunoassay is a technique that primarily focuses on the identification and documentation of high-resolution cellular components within cells and tissue constituents such as proteins and lipopolysaccharides in clinical diagnostics and medical research laboratories. It is used to diagnose diseases, for biological research, and for drug development applications, which is driving the growth of the segment.
- Geography
- North America
- Europe
- Asia
- Rest Of World (ROW)
About 35% of the overall market growth is expected to come from North America during the forecast period. The growth of the regional market can be attributed to high healthcare spending and an increase in promotions about the use of POC tests for the early detection of diseases.
Get deeper insights into the contribution of each business segment and region toward the growth of the global market by purchasing our full report. Start by Downloading a Free Sample
In-vitro Diagnostics Market 2022-2026: Vendor Analysis and Scope
To help businesses improve their market position, the in-vitro diagnostics market provides a detailed analysis of around 25 vendors operating in the market. Some of these vendors include:
- Abbott Laboratories: The company offers in vitro diagnostics such as Alinity H-Series and CELL DYN Ruby.
- Danaher Corp.: The company offers in vitro diagnostics such as HemoCue Hb 801 System.
- DiaSorin SpA: The company offers in vitro diagnostics such as DiaSorin LIAISON Calprotectin Assay.
- F. Hoffmann La Roche Ltd.: The company offers in vitro diagnostics such as Elecsys Anti SARS CoV 2.
- Illumina Inc.: The company offers in vitro diagnostics such as Illumina COVIDSeq Test.
- Agilent Technologies Inc.
- ARKRAY Inc.
- Becton Dickinson and Co.
- BGI Group
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Grifols SA
- Ortho Clinical Diagnostics plc
- QIAGEN NV
- Quest Diagnostics Inc.
- Siemens AG
- Sysmex Corp
- Thermo Fisher Scientific Inc.
In-vitro Diagnostics Market 2022-2026: Key Highlights
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will assist in-vitro diagnostics market growth during the next five years
- Estimation of the in-vitro diagnostics market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the in-vitro diagnostics market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of in-vitro diagnostics market vendors
Related Reports:
- In-vitro Colorectal Cancer Screening Tests Market by End-user and Geography - Forecast and Analysis 2021-2025
- In-Vitro Toxicity Testing Market by End-user and Geography - Forecast and Analysis 2022-2026
In-vitro Diagnostics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.89% |
Market growth 2022-2026 |
USD 33.16 billion |
Market structure |
Fragmented |
YoY growth (%) |
6.03 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key consumer countries |
US, Canada, Germany, China, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Ortho Clinical Diagnostics plc, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.3 Market size 2021
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Technology
- 5.1 Market segments
- Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
- 5.2 Comparison by Technology
- Exhibit 26: Chart on Comparison by Technology
- Exhibit 27: Data Table on Comparison by Technology
- 5.3 Immunoassay - Market size and forecast 2021-2026
- Exhibit 28: Chart on Immunoassay - Market size and forecast 2021-2026 ($ billion)
- Exhibit 29: Data Table on Immunoassay - Market size and forecast 2021-2026 ($ billion)
- Exhibit 30: Chart on Immunoassay - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Immunoassay - Year-over-year growth 2021-2026 (%)
- 5.4 Molecular diagnostics - Market size and forecast 2021-2026
- Exhibit 32: Chart on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
- Exhibit 33: Data Table on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
- Exhibit 34: Chart on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
- 5.5 Clinical chemistry - Market size and forecast 2021-2026
- Exhibit 36: Chart on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
- Exhibit 37: Data Table on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
- Exhibit 38: Chart on Clinical chemistry - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Clinical chemistry - Year-over-year growth 2021-2026 (%)
- 5.6 Hematology - Market size and forecast 2021-2026
- Exhibit 40: Chart on Hematology - Market size and forecast 2021-2026 ($ billion)
- Exhibit 41: Data Table on Hematology - Market size and forecast 2021-2026 ($ billion)
- Exhibit 42: Chart on Hematology - Year-over-year growth 2021-2026 (%)
- Exhibit 43: Data Table on Hematology - Year-over-year growth 2021-2026 (%)
- 5.7 Others - Market size and forecast 2021-2026
- Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
- Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
- Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
- 5.8 Market opportunity by Technology
- Exhibit 48: Market opportunity by Technology ($ billion)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 50: Chart on Market share by geography 2021-2026 (%)
- Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 52: Chart on Geographic comparison
- Exhibit 53: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
- Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
- Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
- Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
- Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
- Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
- Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
- Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
- Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
- Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
- Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ billion)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ billion)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.9 Japan - Market size and forecast 2021-2026
- Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
- Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
- Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
- 7.10 Germany - Market size and forecast 2021-2026
- Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
- Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
- Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.11 Canada - Market size and forecast 2021-2026
- Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
- Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
- Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 90: Market opportunity by geography ($ billion)
8 Drivers, Challenges, and Trends
- 8.1 Market drivers
- 8.2 Market challenges
- 8.3 Impact of drivers and challenges
- Exhibit 91: Impact of drivers and challenges in 2021 and 2026
- 8.4 Market trends
9 Vendor Landscape
- 9.1 Overview
- 9.2 Vendor landscape
- Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 93: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 94: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 95: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 96: Matrix on vendor position and classification
- 10.3 Abbott Laboratories
- Exhibit 97: Abbott Laboratories - Overview
- Exhibit 98: Abbott Laboratories - Business segments
- Exhibit 99: Abbott Laboratories - Key news
- Exhibit 100: Abbott Laboratories - Key offerings
- Exhibit 101: Abbott Laboratories - Segment focus
- 10.4 Danaher Corp.
- Exhibit 102: Danaher Corp. - Overview
- Exhibit 103: Danaher Corp. - Business segments
- Exhibit 104: Danaher Corp. - Key news
- Exhibit 105: Danaher Corp. - Key offerings
- Exhibit 106: Danaher Corp. - Segment focus
- 10.5 DiaSorin SpA
- Exhibit 107: DiaSorin SpA - Overview
- Exhibit 108: DiaSorin SpA - Business segments
- Exhibit 109: DiaSorin SpA - Key news
- Exhibit 110: DiaSorin SpA - Key offerings
- Exhibit 111: DiaSorin SpA - Segment focus
- 10.6 F. Hoffmann La Roche Ltd.
- Exhibit 112: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 113: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 114: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 115: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 116: F. Hoffmann La Roche Ltd. - Segment focus
- 10.7 Illumina Inc.
- Exhibit 117: Illumina Inc. - Overview
- Exhibit 118: Illumina Inc. - Business segments
- Exhibit 119: Illumina Inc. - Key news
- Exhibit 120: Illumina Inc. - Key offerings
- Exhibit 121: Illumina Inc. - Segment focus
- 10.8 Ortho Clinical Diagnostics plc
- Exhibit 122: Ortho Clinical Diagnostics plc - Overview
- Exhibit 123: Ortho Clinical Diagnostics plc - Business segments
- Exhibit 124: Ortho Clinical Diagnostics plc - Key offerings
- Exhibit 125: Ortho Clinical Diagnostics plc - Segment focus
- 10.9 Quest Diagnostics Inc.
- Exhibit 126: Quest Diagnostics Inc. - Overview
- Exhibit 127: Quest Diagnostics Inc. - Business segments
- Exhibit 128: Quest Diagnostics Inc. - Key offerings
- Exhibit 129: Quest Diagnostics Inc. - Segment focus
- 10.10 Siemens AG
- Exhibit 130: Siemens AG - Overview
- Exhibit 131: Siemens AG - Business segments
- Exhibit 132: Siemens AG - Key news
- Exhibit 133: Siemens AG - Key offerings
- Exhibit 134: Siemens AG - Segment focus
- 10.11 Sysmex Corp
- Exhibit 135: Sysmex Corp - Overview
- Exhibit 136: Sysmex Corp - Business segments
- Exhibit 137: Sysmex Corp - Key offerings
- Exhibit 138: Sysmex Corp - Segment focus
- 10.12 Thermo Fisher Scientific Inc.
- Exhibit 139: Thermo Fisher Scientific Inc. - Overview
- Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 141: Thermo Fisher Scientific Inc. - Key news
- Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus
11 Appendix
- 11.1 Scope of the report
- 11.2 Inclusions and exclusions checklist
- Exhibit 144: Inclusions checklist
- Exhibit 145: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 146: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 147: Research methodology
- Exhibit 148: Validation techniques employed for market sizing
- Exhibit 149: Information sources
- 11.5 List of abbreviations
- Exhibit 150: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article